Is Dutch Govt Pursuing Wider EU Discussion And Collaboration On Pricing and Reimbursement?
Executive Summary
An initiative from the Netherlands to ensure that pharmaceutical companies market centrally approved medicines in all EU member states is probably intended to fuel discussions on the differences in national pricing and reimbursement policies, says a legal expert.